Urological Telesurgery Proves as Reliable as Local Robotic Surgery in Randomised Trial
February 6, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
LYNKUET
Synonyms :
elinzanetant
Class :
Neurokinin Receptor Antagonists
Brand Name :
LYNKUET
Synonyms :
elinzanetant
Class :
Neurokinin Receptor Antagonists
Adult dosing
Menopausal Vasomotor Symptoms
Awaiting FDA approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause
Awaiting FDA approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause
Actions:
Elinzanetant is a neurokinin-1,3 receptor antagonist that works by blocking the activity of neurokinin B (NKB) and substance P, two neurotransmitters involved in regulating body temperature and reproductive hormone pathways.
During menopause, declining estrogen levels lead to increased NKB signaling in a region of the hypothalamus known as the median preoptic nucleus, which plays a key role in thermoregulation. This overactivation disrupts the body’s temperature control, resulting in vasomotor symptoms (VMS) such as hot flashes and night sweats.
Frequency Defined
Headache
Fatigue or asthenia
Somnolence (sleepiness/drowsiness)
Dizziness
Diarrhea
Rash
Muscle spasms/cramping
Black Box Warning
May cause central nervous system effects and daytime impairment (e.g., drowsiness, dizziness) patients advised not to drive or operate machinery if affected.
Increased liver enzyme values were observed and require monitoring of liver function.
Contraindication/Caution:
Contraindication
Pregnancy and breastfeeding
Pregnancy Warnings:
Pregnancy category: N/A
Lactation: Excretion in human breastmilk is unknown
Pregnancy categories:
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
Elinzanetant is a neurokinin-1,3 receptor antagonist that works by blocking the activity of neurokinin B (NKB) and substance P, two neurotransmitters involved in regulating body temperature and reproductive hormone pathways.
During menopause, declining estrogen levels lead to increased NKB signaling in a region of the hypothalamus known as the median preoptic nucleus, which plays a key role in thermoregulation. This overactivation disrupts the body’s temperature control, resulting in vasomotor symptoms (VMS) such as hot flashes and night sweats.
Administration:
The mode of administration is oral in form of tablets.
Patient information leaflet
Generic Name: elinzanetant
Why do we use elinzanetant?
Elinzanetant is primarily being developed for the management of menopausal vasomotor symptoms (VMS) such as hot flashes and night sweats in women experiencing menopause or perimenopause.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
